With the current liability claim exposure for its Zyprexa product extremely high, Eli Lilly has reported experiencing difficulty obtaining product liability insurance. In its first quarterly report for 2006, the company announced that a restrictive insurance market will force Eli Lilly to self-insure against future product liability claims.
Lilly has expressed concerns regarding its ability to collect on past insurance claims. Lilly is currently litigating against insurance carriers in both Indiana and Bermuda that have attempted to rescind policies.
In addition, a new claim filed July 24, 2006 in Mississippi now looms. Attorney general, Jim Hood, has filed suit against Lilly charging the company with promoting Zyprexa for unapproved uses.
For more on the Lilly Zyprexa liability issues see:
http://www.opednews.com/articles/genera_evelyn_p_060807_zyprexa_lawsuits___e.htm